-
-
Mylan Pharmaceutical has manufactured a generic version of Sofosbuvir 400 mg Tablets, used with other antiviral medications to treat chronic (long-lasting) hepatitis C, in India under the brand name Myhep.
Sofosbuvir 400 mg (Myhep) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is a nucleotide analogue HCV polymerase inhibitor, meaning it blocks the polymerase enzyme which the virus must use to reproduce.
Myhep is expected to improve the way Hepatitis C is treated in India. The treatment is also expected to be cost effective, which means more people can afford the drug and get rid of the disease at an early stage. Myhep Tablets cost very less rate which is 50 times less comparing to Original Drug.
Read more ……
-
You must be logged in to post a comment.